385 related articles for article (PubMed ID: 16103605)
21. [Effectiveness of praziquantel as an antihelmintic agent in the treatment of bilharziasis].
Doehring E; Ehrich JH
Monatsschr Kinderheilkd; 1986 May; 134(5):282-4. PubMed ID: 3088435
[TBL] [Abstract][Full Text] [Related]
22. Effect of a combination of the new antischistosomal drug Ro 15-5458 and praziquantel on different strains of Schistosoma mansoni infected mice.
Kamel G; Metwally A; Guirguis F; Nessim NG; Noseir M
Arzneimittelforschung; 2000 Apr; 50(4):391-4. PubMed ID: 10800639
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and antischistosomal activity of a new 2-nicotinoyl dipeptide analogue of praziquantel.
Abo-Ghalia MH; Soliman AE
Arzneimittelforschung; 1996 Feb; 46(2):207-9. PubMed ID: 8720316
[TBL] [Abstract][Full Text] [Related]
24. The contribution of host-related factors to low cure rates of praziquantel for the treatment of Schistosoma mansoni in Senegal.
van Lieshout L; Stelma FF; Guissé F; Falcao Ferreira ST; Polman K; van Dam GJ; Diakhate M; Sow S; Deelder A; Gryseels B
Am J Trop Med Hyg; 1999 Nov; 61(5):760-5. PubMed ID: 10586908
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of praziquantel against Schistosoma mansoni in northern Senegal.
Picquet M; Vercruysse J; Shaw DJ; Diop M; Ly A
Trans R Soc Trop Med Hyg; 1998; 92(1):90-3. PubMed ID: 9692165
[TBL] [Abstract][Full Text] [Related]
26. Epidemiological studies on Schistosoma mansoni infection in the western region of Saudi Arabia using the potassium hydroxide stool digestion technique.
Ghandour AM; al-Robai AA; Doenhoff M; Banaja AA
J Trop Med Hyg; 1995 Feb; 98(1):57-63. PubMed ID: 7861481
[TBL] [Abstract][Full Text] [Related]
27. Praziquantel versus praziquantel associated with immunomodulators in mice infected with schistosoma mansoni: A systematic review and meta-analysis.
Silva JCS; Bernardes MVAS; Melo FL; Sá MPBO; Carvalho BM
Acta Trop; 2020 Apr; 204():105359. PubMed ID: 31987779
[No Abstract] [Full Text] [Related]
28. Efficacy and Safety of Moxidectin, Synriam, Synriam-Praziquantel versus Praziquantel against Schistosoma haematobium and S. mansoni Infections: A Randomized, Exploratory Phase 2 Trial.
Barda B; Coulibaly JT; Puchkov M; Huwyler J; Hattendorf J; Keiser J
PLoS Negl Trop Dis; 2016 Sep; 10(9):e0005008. PubMed ID: 27636542
[TBL] [Abstract][Full Text] [Related]
29. A comparison of the antischistosomal effect of levo- and dextro-praziquantel on Schistosoma japonicum and S. mansoni in mice.
Tanaka M; Ohmae H; Utsunomiya H; Nara T; Irie Y; Yasuraoka K
Am J Trop Med Hyg; 1989 Aug; 41(2):198-203. PubMed ID: 2505624
[TBL] [Abstract][Full Text] [Related]
30. Effect of adamantylamide dipeptide on reinfection resistance after primary infection eradication in experimental Schistosomiasis mansoni.
Botros S; Mahmoud S; Hassan S; Ibrahim A; Zidek Z; Masek K
Arzneimittelforschung; 1996 Jan; 46(1):74-8. PubMed ID: 8821522
[TBL] [Abstract][Full Text] [Related]
31. Assessment of efficacy of praziquantel against Schistosoma mansoni infection.
Massoud AA; el Kholy AM; Anwar WA
J Trop Med Hyg; 1984 Jun; 87(3):119-21. PubMed ID: 6512904
[TBL] [Abstract][Full Text] [Related]
32. Seasonality as a determinant of the efficacy of praziquantel in population-based chemotherapy: lessons from the practice.
Abu-Elyazeed RR; Mansour NS; Youssef FG; Boghdadi AM; el Khoby TA; Hassanein YA; el Gamal RR
J Egypt Soc Parasitol; 1998 Apr; 28(1):1-7. PubMed ID: 9617037
[TBL] [Abstract][Full Text] [Related]
33. Assessment of the potential therapeutic effects of omeprazole in Schistosoma mansoni infected mice.
Ellakany AR; Elgendy DI; Alshenawy HA; Abdel Ghaffar AE
Parasitol Res; 2019 Dec; 118(12):3399-3408. PubMed ID: 31655904
[TBL] [Abstract][Full Text] [Related]
34. Praziquantel side effects and efficacy related to Schistosoma mansoni egg loads and morbidity in primary school children in north-east Ethiopia.
Berhe N; Gundersen SG; Abebe F; Birrie H; Medhin G; Gemetchu T
Acta Trop; 1999 Jan; 72(1):53-63. PubMed ID: 9924961
[TBL] [Abstract][Full Text] [Related]
35. Treatment with praziquantel of schoolchildren with concurrent Schistosoma mansoni and S. haematobium infections in Gezira, Sudan.
Kardaman MW; Fenwick A; el Igail AB; el Tayeb M; Daffalla AA; Dixon HG
J Trop Med Hyg; 1985 Apr; 88(2):105-9. PubMed ID: 3897559
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and safety of praziquantel and dihydroartemisinin piperaquine combination for treatment and control of intestinal schistosomiasis: A randomized, non-inferiority clinical trial.
Mnkugwe RH; Minzi O; Kinung'hi S; Kamuhabwa A; Aklillu E
PLoS Negl Trop Dis; 2020 Sep; 14(9):e0008619. PubMed ID: 32966290
[TBL] [Abstract][Full Text] [Related]
37. Evidence for a long-term effect of a single dose of praziquantel on Schistosoma mansoni-induced hepatosplenic lesions in northern Uganda.
Frenzel K; Grigull L; Odongo-Aginya E; Ndugwa CM; Loroni-Lakwo T; Schweigmann U; Vester U; Spannbrucker N; Doehring E
Am J Trop Med Hyg; 1999 Jun; 60(6):927-31. PubMed ID: 10403322
[TBL] [Abstract][Full Text] [Related]
38. Randomized comparative trials of single doses of the newer antischistosomal drugs at Mwanza, Tanzania. I. Praziquantel and oxamniquine for the treatment of schistosomiasis mansoni.
Rugemalila JB; Asila J; Chimbe A
J Trop Med Hyg; 1984 Dec; 87(6):231-5. PubMed ID: 6398833
[TBL] [Abstract][Full Text] [Related]
39. Effectiveness of hyperbaric oxygen for experimental treatment of schistosomiasis mansoni using praziquantel-free and encapsulated into liposomes: assay in adult worms and oviposition.
Frezza TF; de Souza AL; Prado CC; de Oliveira CN; Gremião MP; Giorgio S; Dolder MA; Joazeiro PP; Allegretti SM
Acta Trop; 2015 Oct; 150():182-9. PubMed ID: 26215128
[TBL] [Abstract][Full Text] [Related]
40. A novel praziquantel solid lipid nanoparticle formulation shows enhanced bioavailability and antischistosomal efficacy against murine S. mansoni infection.
Radwan A; El-Lakkany NM; William S; El-Feky GS; Al-Shorbagy MY; Saleh S; Botros S
Parasit Vectors; 2019 Jun; 12(1):304. PubMed ID: 31208446
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
